1. Diagnostic Role of NT-proBNP in Patients with Cardiac Amyloidosis Involvement: A Meta-Analysis;Zhang;Arq Bras Cardiol,2022
2. Cardiac amyloidosis and its new clinical phenotype: heart failure with preserved ejection fraction;Mesquita;Arq Bras Cardiol,2017
3. Clinical, laboratory, and imaging profile in patients with systemic amyloidosis in a Brazilian Cardiology Referral Center;Fernandes;Arq Bras Cardiol,2022
4. Position statement on diagnosis and treatment of cardiac amyloidosis – 2021;Simões;Arq Bras Cardiol,2021
5. Emerging topics in heart failure: new paradigms in cardiac amyloidosis;Simões;Arq Bras Cardiol,2020